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Skin tumors can be produced experimentally
by a variety of methods. Among the most potent
experimental carcinogens are certain hydrocar-
bons such as 9: 10-dimethyl-1 :2-benzanthracene
(DMBA). Ultraviolet rays in the sunburn range
(2900 A° to 3200 A°) and to a lesser extent shorter
ultraviolet wave lengths also have tumorigenic
properties (1). However, the effect of the
carcinogenic rays on chemical tumor production
has not been clarified. Some investigators found
that ultraviolet light and visible light enhanced
chemical eareinogenesis (2—5); others could not
confirm this association (6—8). The present study
Carcinogen. A 0.5 per cent solution of 9:10-
dimethyl-1:2-benzanthracene in acetone (DMBA)
was used as the carcinogen.
Light source. The ultraviolet light source con-
sisted of an air-cooled, hot quartz, high pressure
Hanovia contact lamp. At a distance of 3.4 em.
this source produced 15.79 X 10 ergs/cm2/sec in
the ultraviolet spectrum between 2200 A and 4000
A; 1.74 X 10 ergs/cm2/see in the mid-ultraviolet
spectrum between 2800 A and 3200 A; and 6.03
X 10 ergs/cm2/sec in the short ultraviolet spec-
trum between 2200 A and 2800 A (measurements
were made with a Hanovia ultraviolet meter model
number AV-971).
TABLE I
Group Ais *ee Proredure Method
I (control 1) 30 8 0.1 ml of 0.5% DMBA. Applied to posterior half of back.
II (UVL 1) 30 8 0.1 ml of 0.5% DMBA.
2.61 X 10 ergs/cm2/sec
of mid-UVL energy (2800—
3200 A).
Applied to posterior half of back
then exposed to UVL at a distance
of 3.4 cm. for 30 see. per day for
five days.
III (IJVL 2) 30 8
10
2.61 X 10 ergs/em°/sec of
mid-UVL energy (2800—
3200 A).
0.1 ml of 0.5% DMBA.
Posterior half of back was exposed
to UVL at a distance of 3.4 cm.
for 30 sec. per day for five days.
Applied to posterior half of back 10
days after last UVL exposure.
IV (control 2) 27 10 0.1 ml of 0.5% DMBA. Applied to posterior half of back.
MATEEJALS AND METHODS
Animals. The experimental animals were inbred
male Swiss strain albino mice. They were housed
in metal cages and fed on unrestricted quantities
of Wayne Lab Blox and water. They were exposed
to very little visible light except during periods of
observation and treatment.
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PE0cEDURE
The mice were divided into four groups of
approximately equal numbers.
Croup I (control 1) consisted of 30 animals eight
weeks old. Two drops (0.1 ml) of the 0.5 per cent
solution of DMBA were applied to the posterior
half of the back of each mouse.
In Group II (IJVL 1) 30 mice eight weeks old
were also treated with DMBA in the same manner.
Then the treated area was exposed to ultraviolet
light from the unfiltered hot quartz source at a
distance of 3.4 em. for thirty seconds a day over
the next five days. Each animal received a total of
2.61 X 10 ergs/cm2/see of mid-ultraviolet energy
(2800 to 3200 A).
In Group III (UVL 2) 30 mice eight weeks old
were given the identical light exposure over a five
day period. Ten days after the last exposure these
73
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ultraviolet reactions on chemical tumorigenesis.
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mice were treated with two drops of the 0.5 per
cent DMBA solution as in Groups I and II. The
animals in Group III were ten weeks old at the
time the carcinogen was applied.
Group IV (control 2) consisted of 27 mice ten
weeks old who were treated with two drops of the
DMBA solution without prior ultraviolet ex-
posure.
Biopsy specimens were taken from the right side
TABLE II
of the posterior one-third of the back of all 117
mice just prior to the application of the car-
cinogen. It should be emphasized that no animal
received more than one treatment with DMBA.
The animals were examined at regular intervals
for a period of four months. The early thiekenings
and plaque formations were not included in our
tumor counts, but they were observed separately.
Only individual papillomas or growths which
persisted for more than two weeks were included
in our tabulations.
Stage of Hair Cycle at Time of DMBA
RESULTS
The biopsy Specimens revealed that the hairGrowing
cycle follicles in most of the animals in Group I and
II were in a resting stage (Table II). In Groups
4/28 III and IV the number of mice with growing
5/25 follicles approximately equaled the number with
17/30 resting follicles.
13/27 Hair loss, thickening and crust formation, or
keratotic skin changes appeared in all animals
by 14 to 17 days after the application of DMBA
regardless of the state of the hair cycle (Table
III). These initial signs of irritation by the
carcinogen were unexpected in the animals
I (control 1)
Hair Loss
Thickening and
keratosis or
crust
II (UVL 1)
Hair Loss
Thickening and
keratosis or
crust
III (UVL 2)
Hair Loss
Thickening and
keratosis or
crust
IV (control 2)
Hair Loss
Thickening and
keratosis or
crust
Effect of 0.5% DMBA on Mouse Skin5
* Only animals without tumors were included in this table.
t Age of mice at time of DMBA application.
t Days after DMBA application.
§ One animal died by the 10th day after DMBA application.
Application5
Group
I (control Ut
II (UVL l)t
III (TJVL 2)
IV (control 2)
Age at time
of biopsy
8 weeks
8 weeks
10 weeks
10 weeks
Resting
cycle
24/28
20/25
13/30
14/27
* The hair cycle was determined by histologi-
cal examination.
t The discrepancy in number of mice in Groups
I and II was due to technical difficulties with the
tissues from a few mice.
Group
TABLE III
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28/30
30/30
30/30
30/30
Agct
8 weeks
8 weeks
10 weeks
10 weeks
lot
29/29
29/29
30/30
30/30
29/30
30/30
25/27
27/27
lit
29/29
29/29
30/30
29/30
30/30
29/30
27/27
27/27
241
28/28
28/28
27/29
27/29
25/27
26/27
27/27
27/27
311 391
27/27 17/20
27/27 17/20
24/26 20/23
24/26 20/23
21/26 9/20
21/26 9/20
26/27 6/23
24/27 1/23
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TABLE IV
Tumor Formation
Mice with tumors
. roup First tumor (daysafter DMBA)
per survivors
70
days*
115
days*
Total
tumorst
Group I 24 days 9/29 9/26 11/29
(control 1) (1 mouse)
Group II 24 days 4/28 4/28 6/30
(UVL 1) (1 mouse)
Group III 24 days 9/30 9/30 9/30
(TJVL 2) (3 mice)
Group IV 35 days 4/27 3/26 4/27
(control 2) (2 mice)
* Time in days after the application of the
DMBA.
t Total tumors by 115 days per survivors at
time of appearance of the first tumor.
1 animal died before the first tumor appeared.
§ This delay in time of first tumor appearance
is not significant.
TABLE V
UVL Response in Group III (UVL 2)
Treatment* Reaction 3 daysf
26/30
days7
24/30UVL X 5 days Hair Loss
to 8 week old Thickening of 14/30 5/30
mice skin
* 2.61 X 10 ergs/cm2/sec total mid UVL energy.
Days after last IJVL exposure
Day of application of DMBA.
with growing hair (9—11). They may have been
due to the combination of the biopsy and DMBA
application (12). Recovery from these changes
was much slower in Groups I and II in which
most of the animals had resting hair follicles.
Transient plaque formation appeared in 68
per cent of Group I and in 59 per cent of Group
II. In Group III plaques occurred in 58 per
cent of the animals despite the fact that less
than one half of these mice had resting hair
follicles. In contrast only 11 per cent of Group
IV developed plaques. Though these plaques
do not necessarily progress to tumor formation,
they have been classified as precancerous lesions
(13). The difference in plaque formation in
Groups III and IV is statistically significant as
analyzed by the chi2 method (P <0.01).
The first tumors appeared at approximately
the same time in all four groups (Table IV).
In Group I (control 1) 38 per cent of the mice
developed tumors by 115 days. In Group II
(UVL 1) 20 per cent developed tumors. In
Group III (IJVL 2) 30 per cent of the mice
formed tumors and 15 per cent of the mice in
Group IV (control 2) developed the growths.
The differences in tumor formation between
Groups I and II and between Groups III and
IV are not statistically significant as analyzed
by the chi2 method (P = not significant).
The reactions of the mice in Group III to the
ultraviolet exposures are tabulated in Table V.
Hair loss appeared early and thickening of the
exposed skin was common. At the time of the
application of the DMBA to this group, 24 of
the mice showed hair loss and 5 of these had
thickened skin.
DISCUSSION
The extensive studies of Berenblum and others
indicate that chemical tumor formation is a
two stage process (10, 14, 15). The first stage
consists of the initiation by the carcinogen of
latent tumor cells or tumor potential. The
second phase is called the promoting stage.
Repeated applications for several weeks of the
carcinogen or certain noncarcinogenic agents will
accelerate or promote tumor growth. In addition,
the carcinogen will remain in the skin long enough
to act as a promoter as well as an initiator if it
is applied only once to animals in the resting
stage of hair development (10).
Many noncarcinogenic promoting procedures
have been described including freezing, scalding,
surgical injury, and applications of turpentine
and croton oil (16). Whether ultraviolet light
can act as an accelerator or promoter of chemical
carcinogenesis is not clear. The data from our
study indicate that short term ultraviolet ex-
posures applied within a few days after treat-
ment with DMBA will not enhance tumor forma-
tion. In fact, there is a suggestion that tumor
production may be inhibited by ultraviolet
treatment. Others have reported that exposure
to sunlight and fluorescent light reduces chemi-
cally induced tumor formation (17, 18). This
apparent tumor inhibition might be due to
oxidation of the DMBA by the light exposures.
Photooxidation of carcinogenic hydrocarbons
results in a quinoid product which is not readily
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bound to protein (19). In support of this view
Miller has found that less hydrocarbon is bound
to cpidermal protein if mice are irradiated after
the carcinogen is applied (20).
Light exposures before the application of the
carcinogen would not be expected to inhibit
tumor formation. Our results support this idea.
Pretreatment with the ultraviolet light appeared
to enhance tumor production and to a greater
extent "premalignant" plaque formation. (Com-
pare Groups III and IV.) This may have been
due to inhibition of hair growth by the ultraviolet
rays leading to a longer period of activity of the
carcinogen. Andreasen and others have shown that
tumor formation and "premalignant" lesions
occur more readily when the hair follicles are
in the resting stage (9, 10, 13). The ultraviolet
induced hair loss noted in Group III at the time
of the DMBA application would perhaps support
this assumption. The biopsy specimens from
Group III were not taken from the areas of
clinical change and did not demonstrate the
ultraviolet induced changes. Another possible
explanation for this apparent stimulation of
tumorigenesis would be initiation of tumor
formation by subcarcinogenic amounts of mid-
ultraviolet energy. Blum's studies suggest that
ultraviolet carcinogenesis is a progressive process
and cannot be divided into stages (1). He feels
that tumor growth starts with the first exposure.
Though the amounts of the mid-ultraviolet
light used in our study would not be expected
to produce clinical tumors, perhaps the growth
rate was increased by the subsequent application
of DMBA. Other chemical substances such as
croton oil have been shown to accelerate ultra-
violet induced tumor formation (21).
The results of our investigations suggest that
ultraviolet light influences chemical tumor forma-
tion. This influence, however, is determined by a
complex of many factors including the time-dose
relationship and the stage of the hair cycle.
Further studies are in progress to extend the
present series and study other variations.
SUMMARY
1. The effect of acute ultraviolet reactions on
9: 10-dimethyl-1 :2-benzanthracene (DMBA) in-
duced tumorigenesis was investigated.
2. Relatively intense exposures to ultraviolet
rays shortly after the application of the car-
cinogen did not enhance tumor production.
3. Application of the ultraviolet energy prior
to treatment with DMBA appeared to increase
"precancerous" plaque formation and to a
lesser extent tumor production.
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DISCUSSION
DR. VICTOR R. WHRATLEY (Palo Alto, Calif.):
I may havc missed a point here, if so I hope that
you will forgive me, but it is customary to
employ DMBA in benzene solution.
DR. JOHN H. EPsnaN: We used it in acetone.
DR. WHEATLRY: Benzene itself will produce
hair loss in animals, as will a number of other
substances. We observed this out when in-
vestigating the hair loss due to squalene. It is
possible that the observed hair loss may be due to
substances other than the DMBA.
DR. CARROLL F. BUR000N, JR. (Philadelphia,
Pa.): Dr. Urbach, working at Roswell Park, and
more recently at the Skin and Cancer Hospital
in Philadelphia reported at the Spring Meeting
of the American Association for Cancer Research
in Chicago, a definitive follow up on the modifica-
tion of ultraviolet carcinogenesis by photoactive
agents (Journal of Investigative Dermatology,
Volume 32, Number 2, February, 1959, 373—
378).
In this study randomly selected female ICR
Swiss mice were irradiated with 4FF40T12
Westinghouse lamps arranged in parallel with an
aluminum reflector and the output calibrated so
that each group of animals received 34.225 x
10 ergs/cm2 daily, five days weekly for a period
of 175 days.
Under these circumstances 64% of the control
group of mice developed ncoplastic tumors of
the ears. One group of beasts in whom .1%
Atabrine in absolute alcohol was applied to the
cars developed no tumors. In the group of mice
painted with crude coal tar the incubation period
was diminished to twelve weeks for the ap-
pearance of tumors and after 25 weeks of ob-
servation, 100% of the animals had developed
neoplasms on the ears. In the control group
painted with crude coal tar alone and not ex-
posed to ultraviolet, 62% developed car neoplasms.
It is not clear if this is an additive or a potcntia-
tion effect. Additional studies arc currently
being done to further clarify this point.
Da. JOHN M. KNOX (Houston, Texas): This
was certainly an interesting presentation and I
want to compliment Dr. Epstein and his asso-
ciates. Have you used any other type of initant
prior to the application of the carcinogen?
The ultraviolet could produce nonspecific in-
flammatory changes which might alter per-
meability or change the reactivity of the skin
in other ways. Inflammation in itself, therefore,
might account for some of the findings in the
radiation group. This whole subject is extremely
interesting.
DR. JOHN H. EPsTEIN (in closing): I would
like to thank the discusscrs for their most in-
teresting comments. In answer to Dr. Whcatley's
question, benzene alone will produce ulcers as
well as hair loss. This apparently occurs primarily
when the hair is in the resting phase of the
growth cycle. The growing hair phase is less
susceptible to the effect of DMBA and bcnzcnc.
This is why we were surprised to see the loss
of hair with the DMBA applications to the
animals with growing hair. We have found that
acetone alone generally will not cause hair loss
in mice with growing hair.
Concerning Dr. Burgoon's discussion, I am
familiar with Dr. Urbach's preliminary study.
I did not see his final paper. His results did
indicate that ultraviolet light plus the crude
coal tar would cause increase in the number of
tumors formed. This may have been due to a
phototoxic reaction similar to Dr. Knox's findings
with the psoralins. In contrast we suggest that
the DMBA in our study was oxidized by the
ultraviolet rays as has been noted by others.
This oxidation product is supposedly not an
effective carcinogen. Concerning Dr. Knox's
suggestion, we have nut used any other irritant
preceding the application of the carcinogen.
However, other investigators have without any
effect. Thank you again for your interesting
comments.
